Helen Choi, MD
Psychiatry · Tampa, FLNPI 1093042293
Payments from drug & device makers
Across 87 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$337
- Neurocrine Biosciences, Inc.$329
- Johnson & Johnson$195
- Otsuka America Pharmaceutical, Inc.$180
- Lundbeck LLC$136
- Takeda Pharmaceuticals U.S.A., Inc.$92
- plus $402 from 10 others
What the payments were for
- Food & beverage$1,59195%
- Education$805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 18 | $337 |
| Neurocrine Biosciences, Inc. | 15 | $329 |
| Johnson & Johnson | 12 | $195 |
| Otsuka America Pharmaceutical, Inc. | 11 | $180 |
| Lundbeck LLC | 7 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 4 | $77 |
| AbbVie(2 entities) | 3 | $75 |
| Shire North American Group Inc | 3 | $60 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 2 | $40 |
| Brainsway USA Inc | 1 | $36 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
How this compares
$1,670 in reported general payments places this provider in the 65th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 74 | $1,888 |
| Lurasidone Hcl | 12 | $1,195 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 84 | $912 |
| Divalproex Sodium ErDivalproex Sodium | 37 | $870 |
| Quetiapine Fumarate | 72 | $808 |
| Aripiprazole | 40 | $768 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 15 | $670 |
| Duloxetine Hcl | 28 | $485 |
| Escitalopram Oxalate | 23 | $355 |
| Bupropion Hcl SrBupropion Hcl | 19 | $306 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $287 |
| Mirtazapine | 11 | $286 |
| Paroxetine Hcl | 24 | $167 |
| Alprazolam | 30 | $167 |
| Lorazepam | 53 | $150 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Tampa
- Kelley WilsonTampa$11.1M
- Jamie FernandezTampa$2.9M
- Jean FilsTampa$1.1M
- Daniel FallonTampa$724K
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.